Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasuyuki Fujisaka
Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b
PLoS ONE
Multidisciplinary
Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir
International Journal of Current Microbiology and Applied Sciences
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Reliable Resolution of Ambiguous Hepatitis C Virus Genotype 1 Results With the Abbott HCV Genotype Plus RUO Assay
Scientific Reports
Multidisciplinary
Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype
PLoS ONE
Multidisciplinary
Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Pharmacist Intervention in Treatment of Patients With Genotype 1 Chronic Hepatitis C
Journal of Managed Care Pharmacy
Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection
Acta Poloniae Pharmaceutica
Pharmacology
Pharmaceutical Science